CONMED CORPORATION— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$2.33B
↑+0.8% +$20Mvs FY2024
Total Liabilities
$1.29B
↓-3.8% -$51Mvs FY2024
Equity
$1.03B
↑+7.3% +$70Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $2.33B | $2.31B |
| Current Assets | $673M | $640M |
| Cash | $0 | $0 |
| ST Investments | $0 | $0 |
| Receivables | $248M | $238M |
| Inventory | $356M | $347M |
| Other Current | $69M | $56M |
| Non-Current Assets | $1.65B | $1.67B |
| PPE | $113M | $116M |
| Goodwill | $807M | $805M |
| Intangibles | $582M | $618M |
| Investments | $0 | $0 |
| Other Non-Current | $150M | $127M |
| Total Liab+Eq | $2.33B | $2.31B |
| Current Liab. | $315M | $278M |
| Accounts Payable | $94M | $102M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $221M | $176M |
| Non-Current Liab. | $978M | $1.07B |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $978M | $1.07B |
| Equity | $1.03B | $963M |
| Retained Earnings | $589M | $560M |
| Other Equity | $444M | $402M |
QuarterCharts · SEC EDGAR data · CNMD · Comparing FY2025 vs FY2024